Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks
Open Access
- 27 January 2010
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 30 (3) , 216-223
Abstract
Objective: To explore if the addition of pregnancy‐associated plasma protein‐A (PAPP‐A) to maternal factors and biophysical markers yields a significant improvement in the detection of hypertensive disorders before the clinical onset of disease.Methods: Prospective screening study for early preeclampsia (PE), late PE and gestational hypertension (GH) in women attending their first hospital visit at 11+0–13+6 weeks of gestation. The performance of screening for PE and GH by combinations of maternal factors, uterine artery with the lowest pulsatility index (L‐PI), mean arterial pressure (MAP) and serum PAPP‐A was determined.Results: There were 8061 unaffected controls, 37 of whom developed early PE, 128 with late PE and 140 with GH. Compared to the controls, in early PE and late PE MAP and uterine artery L‐PI were increased and PAPP‐A was decreased. In GH PAPP‐A was not significantly different from controls. In screening for a combination of maternal factors, uterine artery L‐PI, MAP and PAPP‐A the detection rate of early PE was 83.8%, at a 5% false‐positive rate. In the prediction of late PE and GH there was no significant improvement from the addition of PAPP‐A to the combination of maternal factors, MAP and uterine artery L‐PI.Conclusion: Measurement of PAPP‐A improves the performance of screening for early PE provided by a combination of maternal factors and biophysical tests at 11–13 weeks. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
Funding Information
- Fetal Medicine Foundation (1037116)
This publication has 23 references indexed in Scilit:
- Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeksUltrasound in Obstetrics & Gynecology, 2009
- First-Trimester Prediction of Early PreeclampsiaHypertension, 2009
- First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2008
- Prediction of pre‐eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small‐for‐gestational ageUltrasound in Obstetrics & Gynecology, 2008
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler and PAPP‐A at 11–14 weeks' gestationUltrasound in Obstetrics & Gynecology, 2007
- Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery DopplerPrenatal Diagnosis, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Subclassification of PreeclampsiaHypertension in Pregnancy, 2003
- Practice bulletin #33: diagnosis and management of preeclampsia and eclampsiaObstetrics & Gynecology, 2002
- Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?BMJ, 2001